advertisement

WGA Rescources

Shen Y 19

Showing records 1 to 19 | Display all abstracts from Shen Y

119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Wei Q
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Singh IP
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Zhu C
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Berdahl JP; Sarkisian SR
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Yuan G; Jin J
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Voskanyan LA
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Zhang J
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Ang RE; Doan LV
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Fan W
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Doan LV
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Piao Y
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Applegate D; Shen Y
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Shao S
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Katz LJ
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Lin S
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Kothe AC
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Xiang J
Journal of Controlled Release 2025; 377: 578-590
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Navratil T
Drugs 2024; 84: 1299-1311
119986 Active trans-corneal drug delivery with ocular adhesive micelles for efficient glaucoma therapy
Shen Y
Journal of Controlled Release 2025; 377: 578-590

Issue 25-1

Change Issue


advertisement

Nidek